Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paul Kittner"'
Autor:
Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofmann, Paul Kittner, Mustafa Kahraman, Marco Heuvelman, Tobias Sikosek, Jennifer Feufel, Jasmin Skottke, Dennis Nötzel, Franziska Hinkfoth, Kaja Tikk, Alberto Daniel-Moreno, Jessika Ceiler, Nathaniel Mercaldo, Florian Uhle, Sandra Uhle, Markus A. Weigand, Mariam Elshiaty, Fabienne Lusky, Hannah Schindler, Quentin Ferry, Tatjana Sauka-Spengler, Qianxin Wu, Klaus F. Rabe, Martin Reck, Michael Thomas, Petros Christopoulos, Bruno R. Steinkraus
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-13 (2022)
Abstract Immunotherapies have recently gained traction as highly effective therapies in a subset of late-stage cancers. Unfortunately, only a minority of patients experience the remarkable benefits of immunotherapies, whilst others fail to respond or
Externí odkaz:
https://doaj.org/article/db0758eed23b499e84eeb809e4369d62
Autor:
Timothy Rajakumar, MD, PhD, Rastislav Horos, PhD, Paul Kittner, BSc, Mustafa Kahraman, PhD, Tobias Sikosek, PhD, Franziska Hinkfoth, MSc, Kaja Tikk, PhD, Nathaniel D. Mercaldo, PhD, Albrecht Stenzinger, MD, Klaus F. Rabe, MD, PhD, Martin Reck, MD, Michael Thomas, MD, Petros Christopoulos, MD, PhD, Bruno R. Steinkraus, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100369- (2022)
Introduction: Patients with advanced, non-oncogene-driven NSCLC with high programmed death-ligand 1 (PD-L1) expression are eligible for treatment with immunotherapy. There is, however, an urgent medical need for biomarkers identifying cases that requ
Externí odkaz:
https://doaj.org/article/b983e5c58aea48b7bee928739fa6ad4a
Autor:
Jakob Steinfeldt, MD, Thore Buergel, MSc, Lukas Loock, MSc, Paul Kittner, BSc, Greg Ruyoga, Julius Upmeier zu Belzen, MSc, Simon Sasse, BSc, Henrik Strangalies, BSc, Lara Christmann, MSc, Noah Hollmann, BSc, Benedict Wolf, BSc, Brian Ference, ProfMD, John Deanfield, ProfMD, Ulf Landmesser, ProfMD, Roland Eils, ProfPhD
Publikováno v:
The Lancet: Digital Health, Vol 4, Iss 2, Pp e84-e94 (2022)
Summary: Background: In primary cardiovascular disease prevention, early identification of high-risk individuals is crucial. Genetic information allows for the stratification of genetic predispositions and lifetime risk of cardiovascular disease. How
Externí odkaz:
https://doaj.org/article/2b6f61e52191473b9f0c39c675338b85
Autor:
Thore Buergel, Jakob Steinfeldt, Greg Ruyoga, Maik Pietzner, Daniele Bizzarri, Dina Vojinovic, Julius Upmeier zu Belzen, Lukas Loock, Paul Kittner, Lara Christmann, Noah Hollmann, Henrik Strangalies, Jana M. Braunger, Benjamin Wild, Scott T. Chiesa, Joachim Spranger, Fabian Klostermann, Erik B. van den Akker, Stella Trompet, Simon P. Mooijaart, Naveed Sattar, J. Wouter Jukema, Birgit Lavrijssen, Maryam Kavousi, Mohsen Ghanbari, Mohammad A. Ikram, Eline Slagboom, Mika Kivimaki, Claudia Langenberg, John Deanfield, Roland Eils, Ulf Landmesser
Publikováno v:
Nature Medicine. NATURE PORTFOLIO
Nature Medicine
Nature Medicine, 28(11), 2309-2320. Nature Publishing Group
Nature Medicine, 28(11)
Nature Medicine
Nature Medicine, 28(11), 2309-2320. Nature Publishing Group
Nature Medicine, 28(11)
Publisher Copyright: © 2022, The Author(s). Risk stratification is critical for the early identification of high-risk individuals and disease prevention. Here we explored the potential of nuclear magnetic resonance (NMR) spectroscopy-derived metabol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79590eeb93c24caf08522f29edcc5b58
https://pure.eur.nl/en/publications/365e0bfa-c941-466b-a9d5-6a6d87690291
https://pure.eur.nl/en/publications/365e0bfa-c941-466b-a9d5-6a6d87690291